Palliative hepatic intraarterial chemotherapy (HIC) using a novel combination of gemcitabine and mitomycin C: Results in hepatic metastases

European Radiology

Volumn 18, Issue 3, 2008, Pages 468-476

  Vogl, Thomas J ^a   Zangos, Stephan ^a   Eichler, Katrin ^a   Selby, J Bayne ^b   Bauer, Ralf W ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Breast cancer; Cholangiocarcinoma; Colorecteral cancer; Gemcitabine; Hepatic intraarterial chemotherapy

Indexed keywords

GEMCITABINE; MITOMYCIN; MITOMYCIN C;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BLOOD TOXICITY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL PROTOCOL; COLORECTAL CARCINOMA; DECREASED APPETITE; DRUG SAFETY; DRUG TOLERABILITY; ESOPHAGUS CARCINOMA; FATIGUE; FEMALE; HUMAN; LEIOMYOSARCOMA; LEUKOPENIA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SIDE EFFECT; STOMACH CANCER; THROMBOCYTOPENIA; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BREAST NEOPLASMS; CHOLANGIOCARCINOMA; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; PALLIATIVE CARE; TREATMENT OUTCOME;

EID: 39049167082     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-007-0781-0     Document Type: Article

References (41)

1. Nucum S, Midgley R, Kerr DJ (2003) Colorectal cancer. Acta Oncol 42(4):263-275
2. Eichbaum MHR, Kaltwasser M, Bruckner T, de Rossi TM, Schneeweiss A, Sohn Ch (2006) Prognostic factors for patients with liver metastases from breast cancer. Breast Cancer Res Treat 96(1):53-62
3. Heinemann V, Artmann A, Beinert T, Dietzfelbinger H, Eiermann W, Gabius S, Harbeck N, Kahlert S, Kau W, Lombardo SM, Lorenz T, Merz P, Pihusch R, Rauthe C, Sattler D, Sauer H, Untch M, Wolf C (2005) Systemische Therapie des metastasierten Mammakarzinoms. In: Sauer H, Tumorzentrum Muenchen (ed) Mammakarzinome - Empfehlungen zur Diagnostik, Therapie und Nachsorge. Zuckschwerdt, Muenchen, pp 225-241
4. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303-1314
5. Anderson CD, Pinson CW, Berlin J, Chari RS (2004) Diagnosis and treatment of cholangiocarcinoma. Oncologist 9:43-57
6. Hejna M, Pruckmayer M, Raderer M (1998) The role of chemotherapy and radiation in the management of biliary cancer: A review of the literature. Eur J Cancer 34(7):977-986
7. Vogl TJ, Zangos S, Eichler K, Yakoub D, Nabil M (2007) Colorectal liver metastases: Regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: An update. Eur Radiol 17(4):1025-1034
8. Dedrick RL (1988) Arterial drug infusion: Pharmacokinetic problems and pitfalls. J Natl Cancer Inst 80:84-89
9. Stephens FO (1983) Pharmacokinetics of intraarterial chemotherapy. Recent Results Cancer Res 86:1-12
10. Chen HSG, Gross JF (1980) Intraarterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 64:31-40
11. Schneider A, Kemeny N, Chapman D, Niedzwiecki D, Odermann P (1989) Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal cancer. Cancer 64:2203-2206
12. Therasse P, Arbuck SG, Eisenhauer E, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian CM, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205-216
13. Damjanovic D, Thompson P, Findlay MPN (2004) Evidence-based update of chemotherapy options for metastatic colorectal cancer. ANZ J Surg 74:781-787
14. Lawes D, Taylor I (2005) Chemotherapy for colorectal cancer - an overview of current management for surgeons. Eur J Surg Oncol 31(9):932-941
15. Hurwitz H, Kabbinavar F (2005) Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancer. Oncology 69(Suppl 3):17-24
16. Noble S, Goa KL (1997) Gemcitabine - a review of its pharmacology and clinical potential in non-small lung cancer and pancreatic cancer. Drugs 54(3):447-472
17. Burris HA, Moore MJ, Anderson J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson F, Dorr FA, Stephens CD, Von Hoff DD (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 15(6):2403-2413
18. Kemeny N, Eid A, Stockman J, Gonen M, Schwartz L, Tetzlaff E, Paty P (2005) Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. J Surg Oncol 91:97-101
19. Kemeny NE, Niedzwiecki D, Hollis DR, Lenz HJ, Warren RS, Naughton MJ, Weeks JC, Sigurdson ER, Herndon JE, Zhang C, Mayer RJ (2006) Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24:1395-1403
20. Kemeny N, Jarnagin W, Paty P, Gönen M, Schwartz L, Morse M, Leonard G, D'Agnelica M, DeMatteo R, Blumgart L, Fong Y (2005) Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23:4888-4896
21. Ducreux M, Ychou M, Laplanche A, Gamelin E, Lasser P, Husseini F, Quenet F, Viret F, Jacob JH, Boige V, Elias D, Delperro JR, Luboinski M (2005) Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: A trial of the Gastrointestinal Group of the Fédération Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol 23:4881-4887
22. Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G (2000) Metastatic breast cancer: Clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59:271-278
23. Insa A, Lluch A, Prosper F, Marugan I, Martinez-Agullo A, Garcia-Conde J (1999) Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: Analysis of 439 patients. Breast Cancer Res Treat 56:67-78
24. Elder EE, Kennedy CW, Gluch L, Carmalt HL, Janu NC, Joseph MG, Donellan MJ, Molland JG, Gilett DJ (2006) Patterns of breast cancer relapse. Eur J Surg Oncol. DOI 10.1016/j.ejso.2006.06.001
25. Okaro AC, Durkin DJ, Layer GT, Kissin MW, Karanjia ND (2005) Hepatic resection for breast cancer metastases. Ann R Coll Surg Engl 87:167-170
26. Elias D, Maisonnette F, Druet-Cabanac M, Ouellet JF, Guinebretiere JM, Spielmann M, Delaloge S (2003) An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 185:158-164
27. Maksan SM, Lehnert T, Bastert G, Herfarth C (2000) Curative liver resection for metastatic breast cancer. Eur J Surg Oncol 26:209-212
28. Pestalozzi BC (2006) Mammakarzinom - therapeutische Fortschritte. Ther Umschau 63(4):255-261
29. O'Shaughnessy J (2005) Extending survival with chemotherapy in metastatic breast cancer. Oncologist 10:20-29
30. Ikeda T, Adachi I, Takashima S, Ogita M, Aoyama H, Sano M, Ando J, Tabei T, Tominaga T, Enomoto K, Kanda K, Fukutomi T, Shimoyama M (1999) A phase I/II study of continous intra-arterial chemotherapy using an implantable reservoir for the treatment of liver metastases from breast cancer: A Japan Clinical Oncology Group (JCOG) Study 9113. Jpn J Clin Oncol 29(1):23-27
31. Arai Y, Sone Y, Inaba Y, Ariyoshi Y, Kido C (1994) Hepatic arterial infusion chemotherapy for liver metastases from breast cancer. Cancer Chemother Pharmacol 33:142-144
32. Lorenz M, Wiesener J, Staib-Sebler E, Encke A (1995) Regional therapy breast cancer liver metastases. Zentralbl Chir 120(10):786-790
33. Zimmermann T, Flechsenhar K, Padberg W (1998) Value of locoregional chemotherapy in liver metastases of breast carcinoma. Zentralbl Chir 123(suppl 5):159-161
34. Schneebaum S, Walker MJ, Young D, Farrar WB, Minton JP (1994) The regional treatment of liver metastases from breast cancer. J Surg Oncol 55(1):26-32
35. Thongprasert S (2005) The role of chemotherapy in cholangiocarcinoma. Ann Oncol 16 (suppl 2):93-96
36. Klebl F, Endlicher E, Kullmann F (2006) Palliative Therapie von Gallengangs- und Gallenblasenkarzinomen. Z Gastroenterol 44:587-598
37. Tanaka N, Yamakado K, Nakatsuka A, Fujii A, Matsumura K, Takeda K (2001) Arterial chemoinfusion therapy through an implanted port system for patients with unresectable intrahepatic cholangiocarcinoma - initial experience. Eur J Radiol 41:42-48
38. Cantore M, Mambrini A, Fiorentini G, Rabbi C, Amagni D, Caudana R, Pennucci C, Sanguinetti F, Lombardi M, Nicoli N (2005) Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors. Cancer 103:1402-1407
39. Burger I, Hong K, Schulick R, Georgiades C, Thuluvath P, Choti M, Kamel I, Geschwind JFH (2005) Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: Initial experiences in a single institution. J Vasc Interv Radiol 16:353-361
40. Vogl TJ, Schwarz W, Eichler K, Hochmuth K, Hammerstingl R, Jacob U, Scheller A, Zangos S, Heller M (2006) Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: A clinical study on maximum tolerable dose and treatment efficacy. J Cancer Res Clin Oncol. DOI 10.1007/s00432-006-0138-0
41. Burris HA (1996) Objective outcome measures of quality of life. Oncology (Williston Park) 10(Suppl 11):131-135